# Marvell Technology, Inc.: overview

MRVL · Nasdaq · CIK 1835632 · [Technology](/sectors/technology.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/mrvl.md) · [Financials](/companies/mrvl/financials.md) · [Filings](/companies/mrvl/filings.md) · [Insiders](/companies/mrvl/insiders.md)

Latest reported revenue: [$2.74bn](/filings/0001835632-26-000025.md) for Q2 FY2027, three months to 2026-08-01, from the 10-Q filed Aug 28, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001835632-26-000025).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,516](/filings/0001835632-25-000197.md) | [1,817 d](/filings/0001835632-26-000011.md) | [1,895](/filings/0001835632-26-000019.md) | [2,006](/filings/0001835632-26-000025.md) | [2,075](/filings/0001835632-25-000197.md) | [2,219 d](/filings/0001835632-26-000011.md) | [2,418](/filings/0001835632-26-000019.md) | [2,739](/filings/0001835632-26-000025.md) |
| Gross margin | % | [23.0%](/filings/0001835632-25-000197.md) | [50.5% d](/filings/0001835632-26-000011.md) | [50.3%](/filings/0001835632-26-000019.md) | [50.4%](/filings/0001835632-26-000025.md) | [51.6%](/filings/0001835632-25-000197.md) | [51.7% d](/filings/0001835632-26-000011.md) | [52.1%](/filings/0001835632-26-000019.md) | [53.1%](/filings/0001835632-26-000025.md) |
| Operating margin | % | [(46.4%)](/filings/0001835632-25-000197.md) | [12.9% d](/filings/0001835632-26-000011.md) | [14.3%](/filings/0001835632-26-000019.md) | [14.5%](/filings/0001835632-26-000025.md) | [17.2%](/filings/0001835632-25-000197.md) | [18.2% d](/filings/0001835632-26-000011.md) | [14.0%](/filings/0001835632-26-000019.md) | [16.8%](/filings/0001835632-26-000025.md) |
| Net margin | % | [(44.6%)](/filings/0001835632-25-000197.md) | [11.0% d](/filings/0001835632-26-000011.md) | [9.4%](/filings/0001835632-26-000025.md) | [9.7%](/filings/0001835632-26-000025.md) | [91.7%](/filings/0001835632-25-000197.md) | [17.9% d](/filings/0001835632-26-000011.md) | [1.4%](/filings/0001835632-26-000025.md) | [11.2%](/filings/0001835632-26-000025.md) |
| Diluted EPS | $ per share | [(0.78)](/filings/0001835632-25-000197.md) | not reported | [0.20](/filings/0001835632-26-000019.md) | [0.22](/filings/0001835632-26-000025.md) | [2.20](/filings/0001835632-25-000197.md) | not reported | [0.04](/filings/0001835632-26-000019.md) | [0.33](/filings/0001835632-26-000025.md) |
| Free cash flow | $m | [461 d](/filings/0001835632-25-000197.md) | [444 d](/filings/0001835632-26-000011.md) | [214](/filings/0001835632-26-000019.md) | [414 d](/filings/0001835632-26-000025.md) | [509 d](/filings/0001835632-25-000197.md) | [259 d](/filings/0001835632-26-000011.md) | [483](/filings/0001835632-26-000019.md) | [479 d](/filings/0001835632-26-000025.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-01-29) | FY2023 (2023-01-28) | FY2024 (2024-02-03) | FY2025 (2025-02-01) | FY2026 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,462](/filings/0001835632-24-000009.md) | [5,920](/filings/0001835632-25-000057.md) | [5,508](/filings/0001835632-26-000011.md) | [5,767](/filings/0001835632-26-000011.md) | [8,195](/filings/0001835632-26-000011.md) |
| Gross margin | % | [46.3%](/filings/0001835632-24-000009.md) | [50.5%](/filings/0001835632-25-000057.md) | [41.6%](/filings/0001835632-26-000011.md) | [41.3%](/filings/0001835632-26-000011.md) | [51.0%](/filings/0001835632-26-000011.md) |
| Operating margin | % | [(7.8%)](/filings/0001835632-24-000009.md) | [4.0%](/filings/0001835632-25-000057.md) | [(10.3%)](/filings/0001835632-26-000011.md) | [(12.5%)](/filings/0001835632-26-000011.md) | [16.1%](/filings/0001835632-26-000011.md) |
| Net margin | % | [(9.4%)](/filings/0001835632-24-000009.md) | [(2.8%)](/filings/0001835632-25-000057.md) | [(16.9%)](/filings/0001835632-26-000011.md) | [(15.3%)](/filings/0001835632-26-000011.md) | [32.6%](/filings/0001835632-26-000011.md) |
| Diluted EPS | $ per share | [(0.53)](/filings/0001835632-24-000009.md) | [(0.19)](/filings/0001835632-25-000057.md) | [(1.08)](/filings/0001835632-26-000011.md) | [(1.02)](/filings/0001835632-26-000011.md) | [3.07](/filings/0001835632-26-000011.md) |
| Free cash flow | $m | [650](/filings/0001835632-24-000009.md) | [1,083](/filings/0001835632-25-000057.md) | [1,034](/filings/0001835632-26-000011.md) | [1,397](/filings/0001835632-26-000011.md) | [1,396](/filings/0001835632-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mrvl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $25.51bn | 85,641,174 |  | Added +21,798,190 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.25bn | 57,898,902 |  | Added +18,793,677 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $16.96bn | 56,933,063 |  | Reduced −74,322,607 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $12.46bn | 41,834,272 |  | Added +18,495,866 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $9.02bn | 30,285,653 |  | Added +19,762,168 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.27bn | 21,126,096 |  | Added +8,541,544 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $6.26bn | 21,015,501 |  | Reduced −12,202,610 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $5.43bn | 18,213,200 | Put | Added +4,493,600 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $5.15bn | 17,293,600 | Call | Added +7,226,200 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $4.38bn | 14,700,948 |  | Added +3,452,921 |

## Recent filings

[All 848 filings](/companies/mrvl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:05 ET | [8-K](/filings/0001193125-26-430424.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-430424 |
| 2026-09-25 | 20:35 ET | [8-K](/filings/0001628280-26-063592.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063592 |
| 2026-08-28 | 20:04 ET | [10-Q](/filings/0001835632-26-000025.md) | Quarterly report, period 2026-08-01 | 0001835632-26-000025 |
| 2026-08-27 | 20:05 ET | [8-K](/filings/0001835632-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-26-000022 |
| 2026-08-19 | 12:25 ET | [8-K](/filings/0001193125-26-356217.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-356217 |
| 2026-07-09 | 21:19 ET | [8-K](/filings/0001193125-26-299843.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-299843 |
| 2026-06-25 | 20:43 ET | [8-K](/filings/0001628280-26-045564.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-045564 |
| 2026-06-11 | 20:33 ET | [8-K](/filings/0001193125-26-267688.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-267688 |
| 2026-05-28 | 20:09 ET | [10-Q](/filings/0001835632-26-000019.md) | Quarterly report, period 2026-05-02 | 0001835632-26-000019 |
| 2026-05-27 | 20:06 ET | [8-K](/filings/0001835632-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001835632-26-000014 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001835632-26-000011.md), filed Mar 11, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1835632
- Tickers: MRVL
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.